News and Events
June 2, 2025
No items found.

Episode 15, “Prof Craig Ritchie: Looking Back at EPAD, Moving Forward in Alzheimer’s Disease"

Play video
No items found.
Scott Berry, Founder of Berry Consultants, interviews Professor Craig Ritchie—specialist in brain health and neurodegenerative diseases, Chief Investigator of EPAD (European Prevention of Alzheimer Dementia), and CEO of Scottish Brain Sciences—for a precise analysis of platform trial methodology in Alzheimer’s research.

On the latest episode of the "In the Interim..." podcast, Scott Berry is joined by Prof. Craig Ritchie, EPAD Chief Investigator and Founder of Scottish Brain Sciences, to challenge the status quo in Alzheimer’s Disease trials.

The European Prevention of Alzheimer’s Dementia (EPAD) was very successful in the development of a readiness cohort built on deep participant phenotyping, engaged participant panels, and longitudinal data collection. A platform trial was developed and ready for multiple investigational arms – yet the platform was unable to initiate a first arm in the platform. Professor Ritchie dissents what happened and why the inability for the platform to take off.

Listen to the full discussion today: https://www.berryconsultants.com/resource/15-prof-craig-ritchie-looking-back-at-epad-moving-forward-in-alzheimers-disease

Download PDF
View